<DOC>
	<DOCNO>NCT00265434</DOCNO>
	<brief_summary>Rhinosinusitis disorder often associate Cystic Fibrosis . They restrict quality life enormously give cause repeat ENT surgery . The basic defect CF dysfunction Chloride channel exocrine gland , lead retention secretion consecutive chronic inflammation bacterial superinfection . The prospective placebo control cross-over study aim evaluation efficacy nasally inhalation Pulmozyme respect mucus retention result inflammation .</brief_summary>
	<brief_title>Nasal Inhalation Dornase Alfa ( Pulmozyme ) Patients With Cystic Fibrosis Chronic Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<criteria>Inclusion Criteria ( important ) : Subject confirm diagnosis cystic fibrosis . Subject chronic recurrent rhinosinusitic disorder . Subject 5 year old . Exclusion Criteria ( important ) : Subject critical condition ( FEV1 &lt; 30 % SaO2 &lt; 93 % ) . Subject ENT surgery within 6 month prior study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>